Urology

Latest News

FDA Issues Complete Response Letter for UTI Therapy
FDA Issues Complete Response Letter for UTI Therapy

June 28th 2022

Spero Therapeutics was seeking approval for tebipenem HBr oral tablets for treatment of adult patients with complicated urinary tract infection. The FDA has requested an additional clinical trial.

Halozyme Launches the Testosterone Replacement Tlando
Halozyme Launches the Testosterone Replacement Tlando

June 7th 2022

FDA Approves Therapy for Rare Liver Disease in Children
FDA Approves Therapy for Rare Liver Disease in Children

October 1st 2021

Pipeline Preview

December 31st 2012

FDA Actions in Brief December 2012

December 31st 2012

More News

© 2024 MJH Life Sciences

All rights reserved.